Benefits and Risks of Extended Duration Dual Antiplatelet Therapy after PCI in Patients With and Without Acute Myocardial Infarction

BACKGROUND: The benefits and risks of prolonged dual antiplatelet therapy may be different for patients with acute myocardial infarction (MI) compared with more stable presentations. OBJECTIVE: To assess the benefits and risks of 30 versus 12 months of dual antiplatelet therapy among patients underg...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Coll Cardiol
Hlavní autoři: Yeh, Robert W., Kereiakes, Dean J., Steg, Philippe Gabriel, Windecker, Stephan, Rinaldi, Michael J, Gershlick, Anthony H., Cutlip, Donald E., Cohen, David J., Tanguay, Jean Francois, Jacobs, Alice, Wiviott, Stephen D., Massaro, Joseph M., Iancu, Adrian C., Mauri, Laura
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4678101/
https://ncbi.nlm.nih.gov/pubmed/25787199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2015.03.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky